Fig. 3From: A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinomaValidation of the DEG-based gene signature prognostic model in GSE65858. A Risk score, vital status and heatmap of prognostic genes in the high- and low-risk groups. B Kaplan-Meier survival curves of the relative overall survival of high- and low-risk patients. C The ROC curve for one-year survival of the gene signature and clinical featuresBack to article page